LEUKODYSTROPHY, HYPOMYELINATING, 14
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Diabetes Mellitus
|
0.020 |
AlteredExpression
|
group |
BEFREE |
In conclusion, the present study demonstrated that Ufm 1 could activate NF-κB pathway by downregulating LZAP in macrophage of diabetes and its expression and activation was regulated by JNK/ATF2 and c-Jun pathway.
|
31829413 |
2020 |
Arteriosclerosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
UFM1 is dramatically upregulated under atherosclerosis conditions both in vivo and in vitro.
|
26040753 |
2015 |
Atherosclerosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
UFM1 is dramatically upregulated under atherosclerosis conditions both in vivo and in vitro.
|
26040753 |
2015 |
Diabetes
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, the present study demonstrated that Ufm 1 could activate NF-κB pathway by downregulating LZAP in macrophage of diabetes and its expression and activation was regulated by JNK/ATF2 and c-Jun pathway.
|
31829413 |
2020 |
Hepatitis, Alcoholic
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The DNA methylation levels of Ufm1, Ufc1 and UfSP1 in the promoter CpG region were significantly increased both in AH and NASH patients compared to normal subjects.
|
25290169 |
2014 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In contrast, expression of ufmylation-deficient ASC1 mutant or knockdown of the UFM1-activating E1 enzyme UBA5 prevented tumor growth.
|
25219498 |
2014 |
LEUKODYSTROPHY, HYPOMYELINATING, 14
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Which genes to assess in the NGS diagnostics of intellectual disability? The case for a consensus database-driven and expert-curated approach.
|
30914295 |
2019 |
LEUKODYSTROPHY, HYPOMYELINATING, 14
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development.
|
29868776 |
2018 |
Microcephaly
|
0.420 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development.
|
29868776 |
2018 |
Microcephaly
|
0.420 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.420 |
Biomarker
|
disease |
BEFREE |
Finally, we show that the CNS-specific knockout of Ufm1 in mice causes neonatal death accompanied by microcephaly and apoptosis in specific neurons, further suggesting that the UFM1 system is essential for CNS development and function.
|
27545674 |
2016 |
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle Spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Respiratory Insufficiency
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Growth delay
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absent speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Intellectual Disability
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Spasticity, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Malignant neoplasm of breast
|
0.030 |
Biomarker
|
disease |
BEFREE |
Ufm1 functions in endoplasmic reticulum homeostasis, cell cycle regulation, and dysfunctions of this protein can result in breast cancer and neurological disorders.
|
29251776 |
2018 |